Misoprostol for the treatment of early pregnancy failure

Current Clinical Pharmacology

Volumn 2, Issue 1, 2007, Pages 1-9

  Doggrell, Sheila A ^a  

^a CHARLES DARWIN UNIVERSITY   (Australia)

Author keywords

Early pregnancy failure; Intravaginal; Misoprostol; Missed abortion; Oral; Surgical evacuation

Indexed keywords

CODEINE; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; MIFEPRISTONE; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PETHIDINE; PLACEBO; SULPROSTONE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; AREA UNDER THE CURVE; BLOOD TRANSFUSION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST CONTROL; CURETTAGE; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG COST; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ECONOMIC EVALUATION; FEMALE; FIRST TRIMESTER PREGNANCY; GASTROINTESTINAL SYMPTOM; GYNECOLOGIC SURGERY; HEALTH CARE COST; HUMAN; INDUCED ABORTION; NAUSEA; OBSTETRIC ANALGESIA; PEPTIC ULCER; PHARMACODYNAMICS; POSTOPERATIVE PAIN; PREGNANCY DISORDER; PREGNANCY OUTCOME; PRIORITY JOURNAL; REPEATED DRUG DOSE; REVIEW; SINGLE DRUG DOSE; UTERUS CONTRACTION; VACUUM EXTRACTION; VAGINA BLEEDING; VOMITING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INCOMPLETE; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; ADMINISTRATION, SUBLINGUAL; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MISOPROSTOL; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST;

EID: 34248330463     PISSN: 15748847     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488407779422267     Document Type: Review

References (60)

1. Laferla JL. Spontaneous abortion. Clin Obstet Gynaecol 1986, 13: 105-14.
2. Alberman E. Spontaneous abortions: epidemiology. In Stabile I, Grudzinskas G, Chard T. eds. Spontaneous abortion: diagnosis and treatment. London: Springer-Verlag, 1992: 19-20.
3. Ballagh SA, Harris HA, Demasio K. Is curettage needed for uncomplicated incomplete spontaneous abortion? Am J Obstet Gynecol 1998, 179: 1279-82.
4. Farrell RG, Stonington DJ, Ridgeway RA. Incomplete and inevitable abortion: treatment by suction curettage in the emergency department. Ann Emerg Med 1982, 11: 652-8.
5. Heisterberg L, Hebjorn S, Andersen LF, Petersen H, Sequelae of induced first-trimester abortion. A prospective study assessing the role of postabortal pelvic inflammatory disease and prophylactic antibodies. Am J Obstet Gynecol 1986, 155: 76-80.
6. Jurkovic D, Ross JA, Nicolaides KH. Expectant management of missed miscarriage. Br J Obstet Gynaecol 1998, 105: 670-1.
7. Luise C, Jermy K, May C, et al. Outcomes of expectant management of spontaneous first trimester miscarriage: observational study. BMJ 2002, 324: 873-5.
8. Philip NM, Winikoff B, Moore K, Blumenthal P. A consensus regimen for early abortion with misoprostol. Int J Gynaecol Obstet 2004, 87: 281-3.
9. Bartusevicius A, Barcaite E, Nadisauskiene R. Oral, vaginal and sublingual misoprostol for induction of labor. Int J Gynaecol Obstet 2005, 91: 2-9.
10. Hofmeyr GJ, Walraven G, Gulmezoglu AM, et al. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG 2005, 112: 547-53.
11. Winifoff B. Pregnancy failure and misoprostol - time for a change. N Engl J Med 2005, 353: 834-6.
12. Collins PW. Misoprostol: discovery, development, and clinical applications. Med Res Rev 1990, 10: 149-72.
13. Hussain A, Ahsan F. The vagina as a route for systemic drug delivery. J Contol Release 2005, 103: 301-13
14. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997, 90: 88-92.
15. Creinin MD, Carbonell JL, Schwartz JL, Varela L, Tanda R. A randomized trial of the effect of moistening misoprostol before vaginal administration when used with methotrexate for abortion. Contraception 1999, 59: 11-6.
16. Tang OS, Schweer H, Seyberth HW, Lee SWH, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Human Reprod 2002, 17: 332-6.
17. Khan RU, El-Refaey H, Sharma S, Sooranna D, Stafford M. Oral, rectal, and vaginal pharmacokinetics of misoprostol. Obstet Gynecol 2004, 103: 866-70.
18. Khan RU, El-Refaey H. Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor. Obstet Gynecol 2003, 101: 968-74.
19. Schaff EA, DiCenzo R, Fielding SL. Comparison of misoprostol plasma concentrations following buccal and sublingual administration. Contraception 2005, 71: 22-5.
20. Henshaw RC, Cooper K, el-Refaey H, Smith NC, Templeton AA. Medical management of miscarriage: non-surgical uterine evacuation of incomplete and inevitable spontaneous abortion. BMJ 1993, 306: 894-5.
21. de Jonge ET, Makin JD, Manefeldt E, De Wet GH, Pattinson RC. Randomised clinical trial of medical evacuation and surgical curettage for incomplete miscarriage. BMJ 1995, 311: 662.
22. Ankum WM, Wieringa-de Waard M, Bindels PJE. Management of spontaneous miscarriage in the first trimester: an example of putting informed shared decision making into practice. BMJ 2001, 322: 1343-6.
23. Creinin MD, Moyer R, Guido R. Misoprostol for medical evacuation of early pregnancy failure. Obstet Gynecol 1997, 89: 768-72.
24. Chung T, Leung P, Cheung LP, Haines C, Chang AM. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum treatment of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion. Acta Obstet Gynecol Scand 1997, 76: 248-51.
25. Chung TK, Lee DTS, Cheung LP, Haines CJ, Chang AMZ. Spontaneous abortion: a randomized, controlled trial comparing surgical evacuation with conservative management using misoprostol. Fertil Steril 1999, 71: 1054-9.
26. Pandian Z, Ashok P, Templeton A. The treatment of incomplete miscarriage with oral misoprostol. BJOG 2001, 108: 213-4.
27. Coughlin LB, Roberts D, Haddad NG, Long A. Medical management of first trimester incomplete miscarriage using misoprostol. J Obstet Gynaecol 2004, 24: 67-8.
28. Weeks A, Alia G, Blum J, et al. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstet Gymecol 2005, 106: 540-7.
29. Phupong V, Taneepanichskul S, Kriengsinyot R, et al. Comparative study between single dose 600 microg and repeated dose of oral misoprostol for treatment of incomplete abortion. Contraception 2004, 70: 307-11.
30. El-Refaey H, Rajasekar D, Abdalla M, Calder L, Templeton A. Induction of abortion with mifepristone (RU 486) and oral or vaginal misoprostol. N Engl J Med 1995, 332: 983-7.
31. Wakabayashi M, Tretiak M, Kosasa T et al. Intravaginal misoprostol for medical evacuation of first trimester missed abortion. Prim Care Update Ob Gyns 1998, 5: 176.
32. Zalanyi S. Vaginal misoprostol alone is effective in the treatment of missed abortion. Br J Obstet Gynaecol 1998, 105: 1026-8.
33. Murchison A, Duff P. Misoprostol for uterine evacuation in patients with early pregnancy failures. Am J Obster Gynecol 2004, 190: 1445-6.
34. Ayres D, Teixeira-da-Silva J, Campos I, Patrício B. Vaginal misoprostol in the management of first-trimester missed abortions. Int J Gynaecol Obstet 2000, 71: 53-7.
35. Herabutya Y, O-Prasertsawat P. Misoprostol in the management of missed abortion. Int J Gynaecol Obstet 1997, 56: 263-6.
36. Kovavisarach E, Sathapanachai U. Intravaginal 400 microg misoprostol for pregnancy termination in cases of blighted ovum: a randomised controlled trial. Aust N Z J Obstet Gynaecol 2002, 42: 161-3.
37. Wood SL, Brain PH. Medical management of missed abortion: a randomized clinical trial. Obstet Gynecol 2002, 99: 563-6.
38. Blohm F, Friden BE, Milson I, Platz-Christensen JJ, Nielsen S. A randomised double blind trial comparing misoprostol or placebo in the management of early miscarriage. BJOG 2005, 112: 1090-5.
39. Lister MS, Shaffer LE, Bell JG, Lutter KQ, Moorma KH. Randomized, double-blind, placebo-controlled trial of vaginal misoprostol for management of early pregnancy failures. Am J Obstet Gynecol 2005, 193: 1338-43.
40. Pang MW, Lee TS, Chung TKH. Incomplete miscarriage: a randomized controlled trial comparing oral and vaginal misoprostol for medical evacuation. Hum Reprod 2001, 11: 2283-7.
41. Ngoc NTN, Blum J, Westheimer E, Quan TTV, Winikoff B. Medical treatment of missed abortion using misoprostol. Int J Gynaecol Obstet 2004, 87: 138-42.
42. Sahin HG, Sahin HA, Kocer M. Randomized outpatient clinical trial of medical evacuation and surgical curettage in incomplete miscarriage. Eur J Contracept Reprod Health Care 2001, 6: 141-4.
43. Demetroulis C, Saridogan E, Kunde D, Naftalin AA. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. Hum Reprod 2001, 16: 365-9.2002, 42: 161-3.
44. Muffley PE, Stitely ML, Gherman RB. Early intrauterine pregnancy failure: a randomized trial of medical versus surgical treatment Am J Obstet Gynecol 2002, 187: 321-325.
45. Graziosi GC, Mol BW, Reuwer PJ, Drogtrop A, Bruinse HW. Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Hum Reprod 2004, 19: 1894-9.
46. Graziosi GCM, Bruinse HW, Reuwer RJH, et al. Misoprostol versus curettage in women with early pregnancy failure: impact on women's health-related quality of life. A randomized controlled trial. Hum Reprod 2005, 20: 2340-7.
47. Zhang J, Gilles JM, Barnhart K, et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med 2005, 353: 761-9.
48. Moodliar S, Bagratee JS, Moodley J. Medical vs surgical evacuation of first-trimester spontaneous abortion. Int J Gynaecol Obstet 2005, 91: 21-26.
49. Tam W, Tsui M, Lok I, et al. Long-term reproductive outcome subsequent to medical versus surgical treatment for miscarriage. Hum Reprod 2005, 20: 3555-9.
50. Ngai SW, Chan YM, Tang O, Ho PC. Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage. Hum Reprod 2001, 7: 1493-6.
51. Bagratee JS, Khullar V, Regan L, Moodley J, Kagoro H. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod 2004, 19: 266-71.
52. Gilles JM, Creinin MD, Barnhart K, et al. A randomized trial of saline solution-moistened misoprostol versus dry misoprostol for first-trimester pregnancy failure. Am J Obstet Gynecol 2004, 190: 389-94.
53. Kovavisarach E, Jamnansiri C. Intravaginal misoprostol 600 μg and 800 μg for the termination of early pregnancy failure. Int J Gynaecol Obstet 2005, 90: 208-12.
54. Sifakis S, Angelakis, E, Vardaki E, Fragouli Y, Koutamtakis E. High-dose misoprostol used in outpatient management of first trimester spontaneous abortion. Arch Gynecol Obstet 2005, 272: 183-6.
55. Vejborg TS, Rorbye C, Nilas L. Management of first trimester spontaneous abortion with 800 or 400 μg vaginal misoprostol. Int. J Gynaecol Obstet 2006, 92: 268-9.
56. Wagaarachchi PT, Ashok PW, Smith NC, Templeton A. Medical management of early fetal demise using sublingual misoprostol. BJOG 2002, 109: 462-5.
57. Tang OS, Lau WNT, Ng EHY, Lee SWH, Ho PC. A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first silent miscarriages. Hum Reprod 2003, 18: 176-81.
58. Shan Tang O, Ong CY, Yu Tse K, et al. A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage. Hum Reprod 2005, [Epub ahead of print].
59. Graziosi GCM, van der Steeg JW, Reuwer PHW, Drogtrop AP, Bruinse HW, Mol BWJ. Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Hum Reprod 2005, 20: 1067-71.
60. You JHS, Chung TKH. Expectant, medical or surgical treatment for spontaneous abortion in first trimester of pregnancy: a cost analysis. Hum Reprod 2005, 20: 2873-8.